Abdul Abdirahman
Principal
F-Prime
Principal investing in early-stage B2B software, fintech, and vertical SaaS.
Bio
Professional summary
Kevin Chu is a Principal on F-Prime's healthcare investment team based in San Francisco. He focuses on therapeutics, medical devices, and life science tools, and works with the Eight Roads Ventures China team on F-Prime's healthcare investment efforts in China. His F-Prime bio says he was on the founding team at Shinobi Therapeutics and led investments in Apreo Health, Amber Therapeutics, and Cadence Neuroscience.
Notable companies
Selected portfolio companies the partner has backed
Shinobi TherapeuticsApreo HealthAmber TherapeuticsCadence Neuroscience
Background
Career, education, and skills
Career history
- F-Prime CapitalPrincipal2014 – Present
- IMS Consulting GroupAssociate Consultant
Education
- University of PennsylvaniaBSE, Bioengineering and Engineering Entrepreneurship
Other partners at F-Prime
12 more profiles
Alex Pasteur
Partner
F-Prime
Alex Pasteur is a London-based Partner at F-Prime Capital focused on therapeutics and life sciences.
AP
Anastasiya Sybirna, PhD
Senior Associate
F-Prime
Senior Associate on F-Prime's London healthcare investment team.
Bala Varadhan
Principal
F-Prime
Principal focused on early-stage crypto, blockchain and Web3 investments.
Benjamin Gorman
Principal
F-Prime
Principal investing in early-stage enterprise software and AI.
Betsy Mulé
Principal
F-Prime
Principal investing in enterprise technology and robotics.
Brett Cook
Partner
F-Prime
F-Prime Partner investing in healthcare technology and services companies.
Brian Yordy
Principal
F-Prime
Principal investing in biopharmaceutical and medical technology companies.
Carl Bradford Byers 🚑
Partner
F-Prime
F-Prime Partner and former athenahealth founding CFO investing in healthcare IT and digital health.
Carl Byers
Partner
F-Prime
Carl Byers is a Partner at F-Prime Capital with significant operating experience in healthcare IT, including as a founding team member and CFO of athenahealth.
Chance Mathisen
Associate
F-Prime
Associate focused on early-stage enterprise software investments.
Chong Xu
Partner
F-Prime
F-Prime partner focused on biopharma, medtech, company formation, and China healthcare opportunities.